Target intelligence / Profile preview

Cone-rod homeobox protein (CRX) (CRX)

Target
CRX
Molecular classification
Transcription factor, Homeobox protein, OTX family
01

Overview

Cone-rod homeobox protein (CRX) is a critical transcription factor belonging to the OTX family, primarily expressed in retinal photoreceptor cells and the pineal gland (UniProt: O43186). It plays a fundamental role in the differentiation and survival of rod and cone cells by regulating the expression of essential phototransduction genes such as rhodopsin and color opsins (NCBI Gene: 1406). Mutations in the CRX gene are a significant cause of inherited retinal dystrophies, including Leber congenital amaurosis type 7 and cone-rod dystrophy type 2, which lead to progressive vision loss (OMIM: 602225). While CRX is not currently targeted by conventional small-molecule drugs, it is a major focus for advanced therapeutic modalities like AAV-mediated gene replacement and CRISPR/Cas9 gene editing (PubMed: 32810115). These strategies aim to restore or correct CRX function to halt or reverse retinal degeneration in patients with loss-of-function or dominant-negative mutations.

Other names
CORD2CRDLCA7OTX3Cone-rod homeobox
02

Mechanism of action

Gene augmentation to provide functional copies of the CRX gene or gene editing to correct dominant-negative mutations (PubMed: 32810115).

03

Biological functions

Photoreceptor cell differentiation (UniProt: O43186)Regulation of rhodopsin expression (NCBI Gene: 1406)Maintenance of photoreceptor synaptic integrity (PubMed: 22496631)Circadian rhythm regulation (UniProt: O43186)
04

Disease associations

Cone-rod dystrophy 2 (CORD2) (OMIM: 120970)Leber congenital amaurosis 7 (LCA7) (OMIM: 613829)Retinitis pigmentosa 73 (RP73) (OMIM: 616544)
05

Safety considerations

Dosage-dependent retinal toxicity (overexpression)Immune response to AAV vectorsOff-target genomic alterations
06

Interacting drugs

AAV-CRX (Experimental gene therapy)

1 more in the full profile.

07

Biomarkers

CRX gene mutationsElectroretinogram (ERG) responseOuter nuclear layer (ONL) thickness

Beyond the preview

Go deeper on Cone-rod homeobox protein (CRX) (CRX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cone-rod homeobox protein (CRX) (CRX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call